Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCC-257 in Diabetic Polyneuropathy
NCT00307749Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Mar 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of coleneuramide in diabetic polyneuropathy (DPN) (4 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Nerve Conduction Studies at Week 24. Started Mar 2006; status: completed.
02
Drugs
coleneuramide
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00307749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307749.